Suchergebnisse - "Vandsemb, Esten Nymoen"

PubPharm (8)

1

A patient with minimal myeloma treatment who survived for 20 years

enthalten in: Haematologica | 2024

von Behsen, A. | Vandsemb, E. | Slørdahl, T. | +5

2

enthalten in: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke | 2024

von Olsen, J. | Vandsemb, E. | Treider, M. | +2

3

PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2

enthalten in: The FEBS journal | 2021

von Vandsemb, E. | Rye, M. | Steiro, I. | +6

CommentIn: FEBS J. 2021 Dec;288(23):6674-6676. - PMID 34327809

4

PRL‐3 induces a positive signaling circuit between glycolysis and activation of STAT1/2

enthalten in: The FEBS Journal | 2021

von Vandsemb, E. | Rye, M. | Steiro, I. | +6

5

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

enthalten in: Journal for immunotherapy of cancer | 2020

von Yang, R. | Elsaadi, S. | Misund, K. | +19

6

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

enthalten in: Experimental hematology & oncology | 2018

von Hjort, M. | Hov, H. | Abdollahi, P. | +6

7

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

enthalten in: Experimental hematology & oncology | 2018

von Hjort, M. | Hov, H. | Abdollahi, P. | +6

8

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

enthalten in: Experimental hematology & oncology | 2018

von Hjort, M. | Hov, H. | Abdollahi, P. | +6

1
[1]